Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,460 | 1,490 | 31.08. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.08. | Intelligent Bio Solutions rise on record cartridge sales | 4 | Seeking Alpha | ||
19.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July | 134 | GlobeNewswire (Europe) | NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
15.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 6 | SEC Filings | ||
15.08. | Intelligent Bio Solutions GAAP EPS of -$2.00, revenue of $3.05M | 4 | Seeking Alpha | ||
15.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies | 160 | GlobeNewswire (Europe) | Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue... ► Artikel lesen | |
15.08. | INTELLIGENT BIO SOLUTIONS INC. - 10-K, Annual Report | 2 | SEC Filings | ||
07.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum | 147 | GlobeNewswire (Europe) | Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry... ► Artikel lesen | |
07.08. | EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 | 3 | Benzinga.com | ||
06.08. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 3 | SEC Filings | ||
06.08. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch | 206 | GlobeNewswire (Europe) | NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
30.07. | London transport operator selects INBS for drug screening system | 3 | Investing.com | ||
30.07. | Intelligent Bio Solutions secures drug testing tender with a London transport operator | 4 | Seeking Alpha | ||
30.07. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator | 4 | GlobeNewswire (USA) | ||
25.07. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds | 6 | GlobeNewswire (USA) | ||
23.07. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 2 | SEC Filings | ||
23.07. | Intelligent Bio Solutions advances FDA submission with new test data | 2 | Investing.com | ||
23.07. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience | 302 | GlobeNewswire (Europe) | Data confirms Company's ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent... ► Artikel lesen | |
23.07. | EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level | 5 | Benzinga.com | ||
16.07. | Intelligent Bio Solutions schließt globale Vertriebsvereinbarung für Drogentest-Pflaster | 5 | Investing.com Deutsch | ||
16.07. | Intelligent Bio Solutions expands global reach with SmarTest Patch | 2 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 17,270 | -1,20 % | Eckert&Ziegler mit SCHOCK-MELDUNG: Könnte die Aktie am Montag komplett einbrechen - Experten warnen!!! | ||
DRAEGERWERK | 66,20 | -1,05 % | Draegerwerk AG & Co. KGaA: Dräger bestätigt Q2-Trends und starker Auftragseingang unterstützt Visibilität. HALTEN. | Dräger bestätigt die Ergebnisse für das 2. Quartal 2025 mit einem Umsatzanstieg von 1,8% (wb.) auf 780 Mio EUR und einem EBIT von 20 Mio EUR, was den Wegfall von Einmalerträgen aus dem Vorjahr widerspiegelt.... ► Artikel lesen | |
TELADOC HEALTH | 6,636 | +0,48 % | Teladoc: A Telehealth Titan in Trouble? | ||
ROKU | 82,18 | -0,41 % | Cathie Wood's ARK shifts focus, buys Intellia stock, sells Roku and DraftKings | ||
HIMS & HERS HEALTH | 36,210 | +0,06 % | HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? | ||
BICO GROUP | 2,148 | -0,09 % | BICO Group AB: Publication of BICO Group AB Interim report January-June 2025 | A transformative quarter to secure long-term growth and profitability
Q2 2025 takeawaysBICO entered an agreement to divest MatTek and Visikol to Sartorius for USD 80m on cash and debt free basis, significantly... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,115 | +6,48 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
GERATHERM MEDICAL | 3,090 | -1,59 % | EQS-AFR: Geratherm Medical AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Geratherm Medical AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Geratherm Medical AG: Vorabbekanntmachung... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung geben | EQS-News: SYNLAB AG
/ Schlagwort(e): Kooperation/Studienergebnisse
Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung... ► Artikel lesen | |
ALIGN TECHNOLOGY | 120,75 | -0,54 % | Align Tech Files Patent Infringement Lawsuits Against Angelalign Over Clear Aligner Innovations | WASHINGTON (dpa-AFX) - Align Technology, Inc. (ALGN) announced the filing of patent infringement lawsuits against Angelalign Technology, Inc., a Shanghai-based manufacturer of clear aligners.... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,032 | -1,84 % | Massive News: Volumen- und Kursexplosion durch "InsuJet 2.0"?! | ||
PLUS THERAPEUTICS | 0,459 | -6,23 % | Plus Therapeutics Inc.: Plus Therapeutics Regains Compliance with Applicable Nasdaq Listing Criteria | HOUSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform... ► Artikel lesen | |
HEALWELL AI | 0,808 | -0,62 % | HEALWELL gibt Rekordumsatzwachstum von 645 % im 2. Quartal 2025 bekannt und schließt erstmals Quartal mit positivem bereinigtem EBITDA ab | - HEALWELL erzielte im zweiten Quartal 2025 einen Umsatz aus fortlaufenden Betrieben in Höhe von 40,5 Millionen $ - um 645 % mehr als die 5,4 Millionen $ im zweiten Quartal
2024. Das... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,648 | -0,77 % | RedChip Companies, Inc.: NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks... ► Artikel lesen | |
SPINEWAY | 0,134 | +0,30 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen |